14.9% · mean weight loss at 68 weeks (STEP-1, 2.4 mg weekly)
In stock
20.9% · mean weight loss at 72 weeks (SURMOUNT-1, 15 mg weekly)
In stock
28.3% · mean weight loss at 80 weeks (TRIUMPH-1 phase 3, 12 mg weekly, adults without diabetes)
In stock
Phase 3 · SYNCHRONIZE-1 and -2 trials underway in obesity
In stock
10.8% · mean weight loss at 26 weeks (phase 2, 4.5 mg weekly)
In stock
20.1% · mean weight loss at 48 weeks (phase 2, 9 mg weekly, adults with obesity without type 2 diabetes)
In stock
23.3% · mean weight loss at 48 weeks (phase 2b, eloralintide 9 mg + tirzepatide 15 mg weekly as separate injections, adults with obesity + type 2 diabetes)
In stock
22.7% · mean weight loss at 68 weeks (REDEFINE-1 phase 3 — cagrilintide 2.4 mg + semaglutide 2.4 mg, the related amylin + incretin combination; tirzepatide + cagrilintide itself has no human trial data)
In stock
22.7% · mean weight loss at 68 weeks (REDEFINE-1 phase 3, cagrilintide 2.4 mg + semaglutide 2.4 mg weekly as a fixed-dose combination)
In stock
Most peptide stores sell a hundred compounds. We sell seven — the ones with published human trial data. Weight-loss peptides are what made this field popular, and they're the only ones with the evidence to back it up. We'd rather earn your trust with a short, honest list than your money with a long one. Our philosophy →
No accounts, no payment portals. Checkout takes two minutes.
Browse the catalog or compare mechanisms side by side. Every product page is a full spec sheet — status, trial data, sizes, pricing.
Volume discounts apply automatically — 8% off 2 vials, up to 25% off 6. Checkout takes two minutes, no account needed.
Interac e-Transfer to [email protected]. Ships from Ontario — tracked, discreet, plain packaging.
